Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Billing experts and lawmakers are playing catch-up as providers find ways to get around new surprise-billing laws, leaving patients like Danielle Laskey of Washington state with big bills for emerg… → Read More
Federal officials have ordered the probe after reports that a woman whose water broke at 18 weeks could not get medical care recommended by her doctors to end the pregnancy because hospital officia… → Read More
The Affordable Care Act required that health insurers provide many medical screenings and prevention services at no out-of-pocket cost to health plan members. But insurers and employers may conside… → Read More
Since the U.S. Supreme Court overturned Roe v. Wade in June, ER doctors say they — and their patients — are trapped between state anti-abortion laws and the federal law requiring that care be deliv… → Read More
The president has directed the Federal Trade Commission to carefully consider health industry mergers that may stymie competition and drive up prices. The new Democratic majority appears eager to l… → Read More
Mark Seidman, an assistant director in the Federal Trade Commission’s Bureau of Competition, talks with KHN about efforts to police consolidation among hospitals and other health care providers. → Read More
When Pat Paulson’s son told her he was feeling anxious and depressed at college, Paulson went through her Blue Cross Blue Shield provider directory and started calling mental health therapists. No … → Read More
Consumers who have trouble getting in to see a therapist are turning to online behavioral health providers that offer quick access. But there’s limited research on their effectiveness. → Read More
A Massachusetts health care cost watchdog agency helped block plans of the state’s largest hospital system to expand into the suburbs. Now, other states are looking at whether Massachusetts’ decade… → Read More
CMS chief Chiquita Brooks-LaSure says the agency reserves its power to quickly institute new regulations for “absolute emergencies.” On staffing, nursing home residents might need to wait years to … → Read More
Mass General Brigham’s $2.3 billion expansion plan is raising state officials’ concerns that it will reduce competition and raise the price of care in Massachusetts. It also signals a national shif… → Read More
TV ads and mailings targeting seniors tout Medicare Advantage plans this time of year, but millions choosing traditional Medicare make a costly and difficult decision about Medigap coverage, which … → Read More
Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimate… → Read More
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been… → Read More
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some… → Read More
Responsible for 34% of the nation’s covid death toll, nursing homes and long-term care facilities get slammed by their investors and are told to change. → Read More
Many state Medicaid programs pay out-of-state providers much less than in-state facilities, often making it hard for families with medically complex children to get the care they seek. → Read More
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services. → Read More
One group of maternal health experts in 2016 urged doctors to give all women heparin shots after C-sections, barring specific medical risks for individual patients. But many physicians disagree, qu… → Read More
The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on… → Read More